These should be glorious days for an unfortunate creature known as the OncoMouse. In the mid-1980s, Harvard researchers learned to insert cancer-causing genes, known as oncogenes, into a mouse, making ...

The European Patent Office (EPO) has upheld the patent on the Harvard oncomouse, a mouse strain genetically engineered to be susceptible to cancer. But the patent office has restricted the breadth of ...

The European Patent Office (EPO) has approved a restricted patent on the Harvard OncoMouse, dealing a setback to activists who fought for 9 years to bar EU patents on living organisms. The EPO on July ...

"The focus of this case is a very small animal, namely a mouse - to use a poet's description, a 'Wee, sleekit, cowrin, tim'rous beastie' (R Burns, "To a Mouse", 1785). In all other respects however, ...

The Supreme Court of Canada has rejected Harvard University’s application for a patent on its “oncomouse,” a genetically modified mouse used in cancer studies, ruling that it does not fit the criteria ...

The Supreme Court of Canada in December rejected Harvard University’s application for a patent on its “OncoMouse,” a genetically modified mouse used in cancer studies, ruling that the mouse does not ...